Search

everythinglearnresearchcommunity

for

Search:↓

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

The role of γδT-cells in causing alopecia areata remains unclear.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Special cells can help regrow hair in alopecia areata.

Thymic epithelial cells may be related to skin stem cells.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Platelet Rich Plasma reduces psoriasis symptoms but isn't enough alone for treatment.

ILC1-like cells can independently cause alopecia areata.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

Only one of the two K16 genes on chromosome 17 makes a functional protein for keratin filaments.

Blocking IL-17 might help treat the hair loss condition Lichen planopilaris.

Hair follicle stem cells help heal wounds by turning certain immune cells into ones that reduce inflammation.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

Higher levels of certain immune cells in hair follicles may contribute to alopecia areata.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.